Stockreport

ImmunityBio Announces NCCN® Clinical Practice Guidelines in Oncology Have Been Updated to Include ANKTIVA® Plus BCG for Patients With BCG-Unresponsive NMIBC With Papillary-Only Disease [Ya...

ImmunityBio, Inc.  (IBRX) 
PDF CULVER CITY, Calif., March 17, 2026 BUSINESS WIRE )--ImmunityBio, Inc. ( NASDAQ: IBRX ), a commercial-stage immunotherapy company, today announced that the National Com [Read more]